the aid library

Filter

3876

Gaps in service Utilization and service provision: an analysis of DHS and SPA Malaria data from Malawi, Senegal, and Tanzania

C. Taylor, A. Linn, W. Wang, and H. Moussa (2018) C2

Barriers to the prompt and effective diagnosis and treatment of malaria exist at both the community and health facility level. Household surveys measure malaria case management at the population level with standard indicators that assess treatment-seeking behavior, access to diagnostic testing, and ... more

Malaria morbidity and mortality in Ebola-affected countries caused by decreased health-care capacity, and the potential effect of mitigation strategies: a modelling analysis
recommended

Patrick G T Walker, Michael T White, Jamie T Griffin, et al. (2015)

The ongoing Ebola epidemic in parts of West Africa largely overwhelmed health-care systems in 2014, making adequate care for malaria impossible and threatening the gains in malaria control achieved over the past decade. The study suggests that untreated malaria cases as a result of reduced health-ca ... more

Silicosis - occupational lung disease

Mediclinic Southern Africa Mediclinic Southern Africa (2024) CC2

The Mediclinic article on silicosis provides an overview of this occupational lung disease caused by inhaling silica dust. It explains that inhaled silica particles lead to lung scarring and nodule formation, progressively impairing breathing. The article outlines symptoms such as shortness of breat ... more

National Monkeypox Public Health Response Guidelines

Federal Ministry of Health - Nigeria Centre for Disease Control (2019) CC

Since the re-emergence of monkeypox in Nigeria in September 2017, the Nigeria Centre for Disease Control(NCDC) has continued to receive reports and respond to cases of the disease from States across the country. Between September 2017 when the outbreak started and November 2018, about 300 suspecte ... more

Silicosis - Silicosis is an occupational lung disease caused by inhaling silica dust

Mediclinic Southern Africa Mediclinic Southern Africa (2024) CC2

The Mediclinic Infohub article on silicosis provides an overview of this occupational lung disease caused by inhaling silica dust. It explains that inhaled silica particles lead to lung scarring and nodule formation, progressively impairing breathing. The article outlines symptoms such as shortness ... more

Workplace Pandemic Preparedness. Facilitator Training Manual

Ministry of Health Ghana; NADMO Ghana GiZ Deutsche Gesellschaft für Internationale Zusammenarbeit (2013) C1

The Facilitator Training Manual on Workplace Pandemic Preparedness is a guide developed by GIZ and the Ministry of Health to help organizations prepare for and respond to pandemics while ensuring business continuity. It provides structured guidance on training, risk assessment, prevention, and respo ... more

Coronavirus Disease 2019 (COVID-19) Discharge Instructions

Wolters Kluwer; Clinical Drug Information, Inc. and its affiliates andor licensors (2020) C2

Coronavirus disease 2019 is also known as COVID-19. It is a viral illness that infects the lungs. It is caused by a virus called SARS-associated coronavirus (SARS-CoV-2). This illness was first seen in late 2019 in China and has spread across the world. The signs of COVID-19 are like the flu, and y ... more

What is Asthma?

National Asthma Education Programme (2012) CC2

Asthma: • is one of the most common respiratory complaints in the world today. • affects one in ten children (10%) and one in twenty adults (5%) • can occur for the first time at any age, even in adulthood. •usually begins before the age of five years. A few children affected will � ... more

Integrated Management of Malaria Training - Health Workers Manual

The Ruepublic of Uganda - Ministry of Health (2019) C2

The "Integrated Management of Malaria Training – Health Worker’s Manual" is a practical guide developed by Uganda’s Ministry of Health to train healthcare workers at all levels in the effective diagnosis, treatment, prevention, and management of malaria. It aligns with national malaria treatme ... more

Malaria-Prophylaxe - Patienten-/Kundeninformation

Centrum für Reisemedizin CRM (2025) C2

Malaria is a significant risk for travelers to endemic regions. This patient information highlights essential prevention through mosquito protection and, when indicated, chemoprophylaxis with Atovaquone/Proguanil, Doxycycline, or Mefloquine. Emergency self-treatment options may be carried in specifi ... more

Vaccination and Malaria Prophylaxis Recommendations For UN Personnel on Official Travel and UN Health Care Workers

United Nations Medical Directors (2021) C2

This document, issued by the United Nations Medical Directors in July 2021, outlines vaccination and malaria prophylaxis recommendations for UN personnel travelling on official business and UN healthcare workers. The guidance aims to minimise the risk of vaccine-preventable diseases and malaria by f ... more

Measles: Vaccine Preventable Diseases Surveillance Standards

World Health Organization WHO (2018) C_WHO

Measles is one of the most contagious diseases for humans. It is caused by a paramyxovirus virus, manifesting as a febrile rash illness. The incubation period for measles usually is 10–14 days (range 7–23 days) from exposure to symptom onset. Initial symptoms (prodrome) generally consist of ... more

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for ... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

More time or more money to improve nutrition in Benin Republic?

M. C. D. N. Vodouhe, L. Fakambi Institut National des Recherches Agricoles du Bénin (INRAB) (2015) C2

Children malnutrition eradication in developing countries is a real challenge, especially among vulnerable population. There are so many effort towards women (who are the main care providers) socio-economic situation in order to improve their children nutrition. This article aims to identify the ... more

Malaria in the pregnant traveler

McKinney, K.; Wu, H.; Tan, K. et a (2020) CC

Pregnant travelers face numerous risks, notably increased susceptibility to or severity of multiple infections, including malaria. Because pregnant women residing in areas non-endemic for malaria are unlikely to have protective immunity, travel to endemic areas poses risk of severe illness and pregn ... more

Newborn Care Videos: The Hot Baby

Global Health Media Project (2014) CC

This film shows the baby with a high body temperature: how to examine the baby, cool the baby, and determine if the baby is sick and needs referral (or, in cases where there is no referral option, how to treat the baby). http://globalhealthmedia.org/newborn/videos/the-hot-baby/

COES – Febre Amarela INFORME – Nº 34 /201 7

Ministério da Saúde Secretaria de Vigilância em Saúde, Brazil (2017) C_WHO

Dengue Cheat Sheet

Centers for Disease Control and Prevention CDC (2015) C_CDC

Quick reference guide on clinical management of patients with Dengue

Poster (print): Dengue Warning Signs

World Health Organization World Health Organization WHO (2023) C_WHO

DOWNLOAD (1.13 MB) Many people with dengue can be cared for at home with adequate rest and hydration. But, if you experience any warning signs, go immediately to the nearest medical center.